According to the FDA approval, [68Ga]Ga-PSMA-11 is indicated for patients with suspected prostate cancer metastasis who are potentially curable by surgery or radiation therapy, as well as for patients with suspected prostate cancer recurrence. This evidence concerns the gene FOLH1 and Familial prostate cancer.